Purinergic Receptors in Neurological Diseases With Motor Symptoms: Targets for Therapy

Staging of brain pathology related to sporadic Parkinson’s disease

Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · see citing works

Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS

DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936 · see citing works

Epidemiology of Parkinson's disease

de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110 · see citing works

Identification and characterization of a spinal muscular atrophy-determining gene

Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Bénichou, B., Cruaud, C., Millasseau, P., Zeviani, M., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90460-3 · Cited by 3,995 · see citing works

Multiple Wearable Sensors in Parkinson and Huntington Disease Individuals: A Pilot Study in Clinic and at Home

Adams, J., Dinesh, K., Xiong, M., Tarolli, C. G., Sharma, S., Sheth, N., Aranyosi, A. J., Zhu, W. Y., Goldenthal, S. B., Biglan, K., et al. (2017) · Digital Biomarkers · doi:10.1159/000479018 · Cited by 3,190 · see citing works

Molecular Physiology of P2X Receptors

North, R. A. (2002) · Physiological Reviews · doi:10.1152/physrev.00015.2002 · Cited by 2,919 · see citing works

Actions of caffeine in the brain with special reference to factors that contribute to its widespread use

Fredholm, B. B., Bättig, K., Holmén, J., Nehlig, A., & Zvartau, E. E. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01396-6 · Cited by 2,624 · cited 1× · see citing works

Amyotrophic lateral sclerosis

Kiernan, M. C., Vucic, S., Cheah, B. C., Turner, M. R., Eisen, A., Hardiman, O., Burrell, J. R., & Zoing, M. C. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61156-7 · Cited by 2,603 · see citing works

Immunopathology of multiple sclerosis

Dendrou, C. A., Fugger, L., & Friese, M. A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3871 · Cited by 2,215 · see citing works

Purinergic Nerves

Burnstock, G. (1972) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06930-3 · Cited by 1,852 · see citing works

Huntington's disease: from molecular pathogenesis to clinical treatment

Ross, C. A., & Tabrizi, S. J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70245-3 · Cited by 1,751 · see citing works

P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury

Tsuda, M., Shigemoto‐Mogami, Y., Koizumi, S., Mizokoshi, A., Kohsaka, S., Salter, M. W., & Inoue, K. (2003) · Nature · doi:10.1038/nature01786 · Cited by 1,567 · see citing works

State of play in amyotrophic lateral sclerosis genetics

Renton, A. E., Chiò, A., & Traynor, B. J. (2013) · Nature Neuroscience · doi:10.1038/nn.3584 · Cited by 1,563 · see citing works

The P2Y12 receptor regulates microglial activation by extracellular nucleotides

Haynes, S. E., Hollopeter, G., Yang, G., Kurpius, D., Dailey, M. E., Gan, W.-B., & Julius, D. (2006) · Nature Neuroscience · doi:10.1038/nn1805 · Cited by 1,542 · see citing works

Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)

Constantinescu, C. S., Farooqi, N., O'Brien, K., & Gran, B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01302.x · Cited by 1,523 · see citing works

Huntington Disease

Vonsattel, J. P., & DiFiglia, M. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199805000-00001 · Cited by 1,305 · see citing works

Multiple sclerosis.

Compston, A., & Coles, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 1,184 · see citing works

Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis

Olsson, T., Barcellos, L., & Alfredsson, L. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.187 · Cited by 1,109 · see citing works

Correlation between severity and SMN protein level in spinal muscular atrophy

Lefebvre, S., Burlet, P., Liu, Q., Bertrandy, S., Clermont, O., Münnich, A., Dreyfuss, G., & Melki, J. (1997) · Nature Genetics · doi:10.1038/ng0797-265 · Cited by 1,100 · see citing works

The scientific and clinical basis for the treatment of Parkinson disease (2009)

Olanow, C. W., Stern, M. B., & Sethi, K. D. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a1d44c · Cited by 918 · see citing works

Adenosine: an endogenous regulator of innate immunity

Haskó, G. (2003) · Trends in Immunology · doi:10.1016/j.it.2003.11.003 · Cited by 900 · see citing works

Purinergic signalling in the nervous system: an overview

Abbracchio, M. P., Burnstock, G., Verkhratsky, A., & Zimmermann, H. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.10.001 · Cited by 856 · see citing works

Glutamate excitotoxicity in a model of multiple sclerosis

Pitt, D., Werner, P., & Raine, C. S. (2000) · Nature Medicine · doi:10.1038/71555 · Cited by 855 · see citing works

P2X receptors as cell-surface ATP sensors in health and disease

Khakh, B. S., & North, R. A. (2006) · Nature · doi:10.1038/nature04886 · Cited by 854 · see citing works

Purinergic signalling in neuron–glia interactions

Fields, R. D., & Burnstock, G. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn1928 · Cited by 852 · see citing works

Targeting immunosuppressive adenosine in cancer

Vijayan, D., Young, A., Teng, M. W. L., & Smyth, M. J. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.86 · Cited by 852 · see citing works

Cyclooxygenase-2 (COX-2) in Inflammatory and Degenerative Brain Diseases

Minghetti, L. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.9.901 · Cited by 780 · see citing works

Decreased expression of striatal signaling genes in a mouse model of Huntington's disease

Luthi‐Carter, R. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.9.1259 · Cited by 723 · see citing works

Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non‐adrenergic inhibitory nerves in the gut

Burnstock, G., Campbell, G. R., Satchell, D. G., et al. (1970) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1970.tb10646.x · Cited by 698 · see citing works

Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum

Fink, J. S., Weaver, D. R., Rivkees, S. A., Peterfreund, R. A., Pollack, A. E., Adler, E. M., & Reppert, S. M. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90173-9 · Cited by 649 · see citing works

Mutated Human SOD1 Causes Dysfunction of Oxidative Phosphorylation in Mitochondria of Transgenic Mice

Mattiazzi, M., D’Aurelio, M., Gajewski, C. D., Martushova, K., Kiaei, M., Beal, M. F., & Manfredi, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203065200 · Cited by 616 · see citing works

Presynaptic Control of Striatal Glutamatergic Neurotransmission by Adenosine A 1 –A 2A Receptor Heteromers

Ciruela, F., Casadó, V., Rodrigues, R. J., Luján, R., Burgueño, J., Canals, M., Borycz, J., Rebola, N., Goldberg, S. R., Mallol, J., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3574-05.2006 · Cited by 591 · see citing works

Signaling at Purinergic P2X Receptors

Surprenant, A., & North, R. A. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100630 · Cited by 547 · see citing works

The past, present and future of purine nucleotides as signalling molecules

Burnstock, G. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00125-1 · Cited by 546 · see citing works

Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non‐adrenergic inhibitory nerves in the gut

Burnstock, G., Campbell, G. R., Satchell, D. G., et al. (1997) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1997.tb06815.x · Cited by 546 · see citing works

Striatal Restricted Adenosine A2 Receptor (RDC8) Is Expressed by Enkephalin but Not by Substance P Neurons: An In Situ Hybridization Histochemistry Study

Schiffmann, S. N., Jacobs, O. E., & Vanderhaeghen, J. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb08257.x · Cited by 530 · see citing works

The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABAA receptor alterations in the human basal ganglia in Huntington's disease

Glass, M., Dragunow, M., & Faull, R. L. M. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00008-7 · Cited by 525 · see citing works

The Neurobiology of Childhood Spinal Muscular Atrophy

Crawford, T. O., & Pardo, C. A. (1996) · Neurobiology of Disease · doi:10.1006/nbdi.1996.0010 · Cited by 523 · see citing works

COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord

Yiangou, Y., Facer, P., Durrenberger, P., Chessell, I. P., Naylor, A., Bountra, C., Banati, R. R., & Anand, P. (2006) · BMC Neurology · doi:10.1186/1471-2377-6-12 · Cited by 509 · see citing works

Chronic quinolinic acid lesions in rats closely resemble Huntington's disease

Beal, M. F., Ferrante, R. J., Swartz, K., & Kowall, N. W. (1991) · Journal of Neuroscience · doi:10.1523/jneurosci.11-06-01649.1991 · Cited by 499 · see citing works

P2X7 receptor inhibition improves recovery after spinal cord injury

Wang, X., Arcuino, G., Takano, T., Lin, J. H.-C., Peng, W. G., Wan, P., Li, P., Xu, Q., Liu, Q. S., Goldman, S. A., et al. (2004) · Nature Medicine · doi:10.1038/nm1082 · Cited by 495 · see citing works

The Transcriptome and Metabolic Gene Signature of Protoplasmic Astrocytes in the Adult Murine Cortex

Lovatt, D., Sonnewald, U., Waagepetersen, H. S., Schousboe, A., He, W., Lin, J. H.-C., Han, X., Takano, T., Wang, S., Sim, F. J., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3404-07.2007 · Cited by 488 · see citing works

Multiple Sclerosis: A Review

Goldenberg, M. M. (1973) · BMJ · doi:10.1136/bmj.2.5863.432 · Cited by 488 · see citing works

Activation of Trk neurotrophin receptors in the absence of neurotrophins

Lee, F. S., & Chao, M. V. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061020198 · Cited by 484 · see citing works

Multiple sclerosis: a review

Farace, C., Melguizo, C., Asara, Y., Álvarez, P., Prados, J. C., Tolu, P., Delogu, G., Aránega, A., & Madeddu, R. (2011) · Cited by 458 · see citing works

How does adenosine control neuronal dysfunction and neurodegeneration?

Cunha, R. A. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13724 · Cited by 442 · see citing works

Motoneuron Death Triggered by a Specific Pathway Downstream of Fas

Raoul, C., Estévez, Á. G., Nishimune, H., Cleveland, D. W., deLapeyrière, O., Henderson, C. E., Haase, G., & Pettmann, B. (2002) · Neuron · doi:10.1016/s0896-6273(02)00905-4 · Cited by 432 · see citing works

P2X7Receptor Blockade Prevents ATP Excitotoxicity in Oligodendrocytes and Ameliorates Experimental Autoimmune Encephalomyelitis

Matute, C., Torre, I., Pérez‐Cerdá, F., Pérez‐Samartín, A., Alberdi, E. M., Etxebarria, E., Arranz, A. M., Ravid, R., Antigüedad, A. R., Sánchez‐Gómez, M. V., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0579-07.2007 · Cited by 404 · see citing works

Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha.

Probert, L., Akassoglou, K., Pasparakis, M., Kontogeorgos, G., & Kollias, G. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11294 · Cited by 403 · see citing works

The P2X7 Receptor Channel: Recent Developments and the Use of P2X7 Antagonists in Models of Disease

Bartlett, R., Stokes, L., & Sluyter, R. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008003 · Cited by 395 · see citing works

Adenosine A2A receptors and basal ganglia physiology

Schiffmann, S. N., Fisone, G., Moresco, R. M., Cunha, R. A., & Ferré, S. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.05.001 · Cited by 393 · see citing works

Polyglutamine spinocerebellar ataxias — from genes to potential treatments

Paulson, H. L., Shakkottai, V. G., Clark, H. B., & Orr, H. T. (2017) · Nature reviews. Neuroscience · doi:10.1038/nrn.2017.92 · Cited by 376 · see citing works

Potentiated Necrosis of Cultured Cortical Neurons by Neurotrophins

Koh, J., Gwag, B. J., Lobner, D., & Choi, D. W. (1995) · Science · doi:10.1126/science.7725105 · Cited by 365 · see citing works

Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients

Wiedemann, F. R., Manfredi, G., Mawrin, C., Beal, M. F., & Schon, E. A. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00731.x · Cited by 360 · see citing works

Mouse microglial cells express a plasma membrane pore gated by extracellular ATP

Ferrari, D., Villalba, M., Chiozzi, P., Falzoni, S., Ricciardi‐Castagnoli, P., & Virgilio, F. D. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.4.1531 · Cited by 352 · see citing works

Transformation of Astrocytes to a Neuroprotective Phenotype by Microglia via P2Y1 Receptor Downregulation

Shinozaki, Y., Shibata, K., Yoshida, K., Shigetomi, E., Gachet, C., Ikenaka, K., Tanaka, K. F., & Koizumi, S. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.047 · Cited by 341 · see citing works

A1 Adenosine Receptor Upregulation and Activation Attenuates Neuroinflammation and Demyelination in a Model of Multiple Sclerosis

Tsutsui, S., Schnermann, J. B., Noorbakhsh, F., Henry, S. D., Yong, V. W., Winston, B. W., Warren, K. G., & Power, C. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.4271-03.2004 · Cited by 324 · see citing works

The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases

Raker, V., Becker, C., & Steinbrink, K. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00123 · Cited by 321 · see citing works

An SMN-Dependent U12 Splicing Event Essential for Motor Circuit Function

Lotti, F., Imlach, W. L., Saieva, L., Beck, E., Hao, L. T., Li, D. K., Jiao, W., Mentis, G. Z., Beattie, C. E., McCabe, B. D., et al. (2012) · Cell · doi:10.1016/j.cell.2012.09.012 · Cited by 317 · see citing works

T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis

Sun, J., Link, H., Olsson, T. P., Xiao, B. G., Andersson, G., Ekre, H. P., Linington, C., & Diener, P. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.5.1490 · Cited by 315 · see citing works

Ribonucleoprotein Assembly Defects Correlate with Spinal Muscular Atrophy Severity and Preferentially Affect a Subset of Spliceosomal snRNPs

Gabanella, F., Butchbach, M. E. R., Saieva, L., Carissimi, C., Burghes, A. H. M., & Pellizzoni, L. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000921 · Cited by 315 · see citing works

A Glu-496 to Ala Polymorphism Leads to Loss of Function of the Human P2X7 Receptor

Gu, B. J., Zhang, W., Worthington, R. A., Sluyter, R., Dao‐Ung, P., Petrou, S., Barden, J. A., & Wiley, J. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010353200 · Cited by 314 · see citing works

Adenosine signaling and function in glial cells

Boison, D., Chen, J., & Fredholm, B. B. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.131 · Cited by 306 · see citing works

Immunosuppressive Activities of Adenosine in Cancer

Allard, B., Beavis, P. A., Darcy, P. K., & Stagg, J. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.04.001 · Cited by 292 · see citing works

Neuronal P2X₇Receptors Are Targeted to Presynaptic Terminals in the Central and Peripheral Nervous Systems

Deuchars, S. A., Atkinson, L., Brooke, R. E., Musa, H., Milligan, C. J., Batten, T. F. C., Buckley, N. J., Parson, S. H., & Deuchars, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-18-07143.2001 · Cited by 287 · see citing works

Immunohistochemical and subcellular localization of parkin protein: Absence of protein in autosomal recessive juvenile parkinsonism patients

Shimura, H., Hattori, N., Kubo, S., Yoshikawa, M., Kitada, T., Matsumine, H., Asakawa, S., Minoshima, S., Yamamura, Y., Shimizu, N., et al. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199905)45:5 · Cited by 282 · see citing works

Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis

Menzies, F. M. (2002) · Brain · doi:10.1093/brain/awf167 · Cited by 279 · see citing works

Response of Schwann Cells to Action Potentials in Development

Stevens, B. A., & Fields, R. D. (2000) · Science · doi:10.1126/science.287.5461.2267 · Cited by 267 · see citing works

ATP as a multi-target danger signal in the brain

Rodrigues, R. J., Tomé, Â. R., & Cunha, R. A. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00148 · Cited by 262 · see citing works

Transactivation of Trk Neurotrophin Receptors by G-Protein-Coupled Receptor Ligands Occurs on Intracellular Membranes

Rajagopal, R., Chen, Z.-Y., Lee, F. S., & Chao, M. V. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0010-04.2004 · Cited by 258 · see citing works

The role of the purinergic P2X7 receptor in inflammation

Lister, M. F., Sharkey, J., Sawatzky, D. A., Hodgkiss, J. P., Davidson, D. J., Rossi, A. G., & Finlayson, K. (2007) · Journal of Inflammation · doi:10.1186/1476-9255-4-5 · Cited by 255 · see citing works

Gene expression signatures in motor neurone disease fibroblasts reveal dysregulation of metabolism, hypoxia‐response and RNA processing functions

Raman, R., Allen, S. P., Goodall, G., Kramer, S., Ponger, L., Heath, P. R., Milo, M., Hollinger, H. C., Walsh, T., Highley, J. R., et al. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12147 · Cited by 254 · see citing works

P2X7 Receptors: Channels, Pores and More

Volonté, C., Apolloni, S., Skaper, S. D., & Burnstock, G. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712803581137 · Cited by 254 · see citing works

Combined Use of the Adenosine A2A Antagonist KW-6002 with l-DOPA or with Selective D1 or D2 Dopamine Agonists Increases Antiparkinsonian Activity but Not Dyskinesia in MPTP-Treated Monkeys

Kanda, T., Jackson, M. J., Smith, L. A., Pearce, R. K. B., Nakamura, J., Kase, H., Kuwana, Y., & Jenner, P. G. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7350 · Cited by 248 · see citing works

Programmed Cell Death of Embryonic Motoneurons Triggered through the FAS Death Receptor

Raoul, C., Henderson, C. E., & Pettmann, B. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.5.1049 · Cited by 244 · see citing works

Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease

Cha, J.-H. J., Frey, A. S., Alsdorf, S. A., Kerner, J. A., Kosinski, C. M., Mangiarini, L., Penney, J. B., Davies, S. W., Bates, G. P., & Young, A. B. (1999) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1999.0449 · Cited by 239 · see citing works

Modulation of Synaptic Efficacy and Synaptic Depression by Glial Cells at the Frog Neuromuscular Junction

Robitaille, R. (1998) · Neuron · doi:10.1016/s0896-6273(00)80600-5 · Cited by 239 · see citing works

The Adenosine System Selectively Inhibits TLR-Mediated TNF-α Production in the Human Newborn

Levy, O., Coughlin, M. L., Cronstein, B. N., Roy, R. M., Desai, A., & Wessels, M. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1956 · Cited by 236 · see citing works

Connexin and pannexin mediated cell–cell communication

Scemes, E., Suadicani, S. O., Dahl, G., & Spray, D. C. (2007) · Neuron Glia Biology · doi:10.1017/s1740925x08000069 · Cited by 233 · see citing works

P2X7Receptor Expression after Ischemia in the Cerebral Cortex of Rats

Franke, H., Günther, A., Grosche, J., Schmidt, R., Roßner, S., Reinhardt, R., Faber‐Zuschratter, H., Schneider, D., & Illés, P. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.7.686 · Cited by 227 · see citing works

Calcium signalling in astroglia

Verkhratsky, A., Rodriguez, J. J., & Parpura, V. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.08.039 · Cited by 224 · see citing works

Altered P2X7‐receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration

Dı́az-Hernández, M., Diez-Zaera, M., Sánchez‐Nogueiro, J., Gómez‐Villafuertes, R., Canals, J. M., Alberch, J., Miras‐Portugal, M. T., & Lucas, J. J. (2009) · The FASEB Journal · doi:10.1096/fj.08-122275 · Cited by 224 · see citing works

P2X7 receptors mediate ischemic damage to oligodendrocytes

Domercq, M., Perez‐Samartin, A., Aparicio, D., Alberdi, E., Pampliega, O., & Matute, C. (2010) · Glia · doi:10.1002/glia.20958 · Cited by 221 · see citing works

Blockade of Striatal Adenosine A2AReceptor Reduces, through a Presynaptic Mechanism, Quinolinic Acid-Induced Excitotoxicity: Possible Relevance to Neuroprotective Interventions in Neurodegenerative Diseases of the Striatum

Popoli, P., Pintor, A., Domenici, M. R., Frank, C., Tebano, M. T., Pèzzola, A., Scarchilli, L., Quarta, D., Reggio, R., Malchiodi‐Albedi, F., et al. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01967.2002 · Cited by 218 · see citing works

Genome-Wide Gene-Environment Study Identifies Glutamate Receptor Gene GRIN2A as a Parkinson's Disease Modifier Gene via Interaction with Coffee

Hamza, T. H., Chen, H., Hill-Burns, E. M., Rhodes, S. L., Montimurro, J., Kay, D. M., Tenesa, A., Kusel, V. I., Sheehan, P., Eaaswarkhanth, M., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002237 · Cited by 218 · see citing works

Basic and escalating immunomodulatory treatments in multiple sclerosis: Current therapeutic recommendations

Multiple Sclerosis Therapy Consensus Group (MSTCG), Wiendl, H., Toyka, K. V., Rieckmann, P., Gold, R., Hartung, H. ‐., & Hohlfeld, R. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0061-1 · Cited by 212 · see citing works

Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle-specific SMN expression has no phenotypic effect

Gavrilina, T. O., McGovern, V. L., Workman, E., Crawford, T. O., Gogliotti, R. G., DiDonato, C. J., Monani, U. R., Morris, G. E., & Burghes, A. H. M. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddm379 · Cited by 212 · see citing works

The use of the R6 transgenic mouse models of Huntington’s disease in attempts to develop novel therapeutic strategies

Li, J. Y., Popović, N., & Brundin, P. (2005) · NeuroRx · doi:10.1602/neurorx.2.3.447 · Cited by 211 · see citing works

Ectonucleotidases in the Nervous System

Zimmermann, H. (2006) · Novartis Foundation symposium · doi:10.1002/9780470032244.ch10 · Cited by 210 · see citing works

Extracellular ATP and adenosine: The Yin and Yang in immune responses?

Faas, M. M., Sáez, T., & de Vos, P. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.01.002 · Cited by 210 · see citing works

CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis

Mills, J. H., Thompson, L. F., Mueller, C., Waickman, A. T., Jalkanen, S., Niemelä, J., Airas, L. M., & Bynoe, M. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711175105 · Cited by 209 · see citing works

Adenosine A1 and A2A Receptors in the Brain: Current Research and Their Role in Neurodegeneration

Stockwell, J., Jakova, E., & Cayabyab, F. (2017) · Molecules · doi:10.3390/molecules22040676 · Cited by 206 · see citing works

The role of microglia in multiple sclerosis

Luo, C., Jian, C., Liao, Y., Huang, Q., Wu, Y., Liu, X., Zou, D., & Wu, Y. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s140634 · Cited by 206 · see citing works

Dysregulation of astrocyte–motoneuron cross-talk in mutant superoxide dismutase 1-related amyotrophic lateral sclerosis

Ferraiuolo, L., Higginbottom, A., Heath, P. R., Barber, S. C., Greenald, D., Kirby, J., & Shaw, P. J. (2011) · Brain · doi:10.1093/brain/awr193 · Cited by 204 · see citing works

Mitochondrial electron transport chain complex dysfunction in a transgenic mouse model for amyotrophic lateral sclerosis

Jung, C., Higgins, C. M. J., & Xu, Z. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01112.x · Cited by 202 · see citing works

An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration

Burnstock, G. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.05.031 · Cited by 200 · see citing works

Microarray Analysis of the Cellular Pathways Involved in the Adaptation to and Progression of Motor Neuron Injury in the SOD1 G93A Mouse Model of Familial ALS

Ferraiuolo, L., Heath, P. R., Holden, H. M., Kasher, P. R., Kirby, J., & Shaw, P. J. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1470-07.2007 · Cited by 198 · see citing works

Adenosine A2 receptors: Selective localization in the human basal ganglia and alterations with disease

Martinez-Mir, M. I., Probst, A., & Palacios, J. M. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90038-p · Cited by 198 · see citing works

The role of microglial P2X7: modulation of cell death and cytokine release

He, Y., Taylor, N., Fourgeaud, L., & Bhattacharya, A. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0904-8 · Cited by 194 · see citing works

The cytokine IL‐1β transiently enhances P2X 7 receptor expression and function in human astrocytes

Narcisse, L., Scemes, E., Zhao, Y., Lee, S. C., & Brosnan, C. F. (2004) · Glia · doi:10.1002/glia.20110 · Cited by 191 · see citing works

Involvement of Adenosine A1 and A2A Receptors in the Motor Effects of Caffeine after Its Acute and Chronic Administration

Karcz-Kubicha, M., Antoniou, K., Terasmaa, A., Quarta, D., Solinas, M., Justinova, Z., Pezzola, A., Reggio, R., Müller, C. E., Fuxe, K., et al. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300167 · Cited by 189 · see citing works

Adenosine and ATP Receptors in the Brain

Burnstock, G., Fredholm, B. B., & Verkhratsky, A. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611795347627 · Cited by 188 · see citing works

The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS)

Strong, M. J. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.09.029 · Cited by 185 · see citing works

Neuronal P2X7 Receptors Revisited: Do They Really Exist?

Illes, P., Khan, T. M., & Rubini, P. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.3103-16.2017 · Cited by 179 · see citing works

CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model

Chou, S., Lee, Y., Chen, H., Chiang, M., Lai, H., Chang, H., Wu, Y., Sun, C., Chien, C., Lin, Y., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03029.x · Cited by 174 · see citing works

Antagonistic interaction between adenosine A2A receptors and dopamine D2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia

Ferré, S., O'Connor, W. T., Snaprud, P., Ungerstedt, U., & Fuxé, K. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90521-5 · Cited by 171 · see citing works

Adenosine Receptors and Inflammation

Blackburn, M. R., Vance, C. O., Morschl, É., & Wilson, C. N. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-89615-9_8 · Cited by 170 · see citing works

P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis

Sharp, A. J., Polak, P. E., Simonini, M. V., Lin, S. X., Richardson, J. C., Bongarzone, E. R., & Feinstein, D. L. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-33 · Cited by 167 · see citing works

New insights into molecular structure and function of ecto-nucleotidases in the nervous system

Zimmermann, H., Braun, N., Kegel, B., & Heine, P. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(97)00126-5 · Cited by 166 · see citing works

A His-155 to Tyr Polymorphism Confers Gain-of-Function to the Human P2X7 Receptor of Human Leukemic Lymphocytes

Cabrini, G., Falzoni, S., Forchap, S., Pellegatti, P., Balboni, A., Agostini, P., Cuneo, A., Castoldi, G., Baricordi, O. R., & Virgilio, F. D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.82 · Cited by 164 · see citing works

Use of the A2A adenosine receptor as a physiological immunosuppressor and to engineer inflammation in vivo

Sitkovsky, M. V. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01548-4 · Cited by 164 · see citing works

Different cellular sources and different roles of adenosine: A1 receptor-mediated inhibition through astrocytic-driven volume transmission and synapse-restricted A2A receptor-mediated facilitation of plasticity

Cunha, R. A. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.06.026 · Cited by 163 · see citing works

The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases

Miller, S. D., & Karpus, W. J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90173-2 · Cited by 162 · see citing works

Extracellular ATP and the P2X7receptor in astrocyte-mediated motor neuron death: implications for amyotrophic lateral sclerosis

Gandelman, M., Peluffo, H., Beckman, J. S., Cassina, P., & Barbeito, L. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-33 · Cited by 161 · see citing works

Bioenergetic abnormalities in discrete cerebral motor pathways presage spinal cord pathology in the G93A SOD1 mouse model of ALS

Browne, S. E., Yang, L., DiMauro, J.-P., Fuller, S. W., Licata, S. C., & Beal, M. F. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.01.001 · Cited by 160 · see citing works

Spinal muscular atrophy astrocytes exhibit abnormal calcium regulation and reduced growth factor production

McGivern, J. V., Patitucci, T. N., Nord, J. A., Barabas, M. E., Stucky, C. L., & Ebert, A. D. (2013) · Glia · doi:10.1002/glia.22522 · Cited by 158 · see citing works

Neuronal P2X7 Receptor: Involvement in Neuronal Physiology and Pathology

Miras‐Portugal, M. T., Sebastián‐Serrano, Á., García, L. D. D., & Dı́az-Hernández, M. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.3104-16.2017 · Cited by 154 · see citing works

Dysregulated microRNAs in amyotrophic lateral sclerosis microglia modulate genes linked to neuroinflammation

Parisi, C., Arisi, I., D’Ambrosi, N., Storti, A. E., Brandi, R., D’Onofrio, M., & Volonté, C. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.491 · Cited by 153 · see citing works

Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis

Lederer, C. W., Torrisi, A. A. M., Pantelidou, M., Santama, N., & Cavallaro, S. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-26 · Cited by 152 · see citing works

Rat astroglial P2Z (P2X7) receptors regulate intracellular calcium and purine release

Ballerini, P., Rathbone, M. P., Iorio, P. D., Renzetti, A., Giuliani, P., DʼAlimonte, L., Trubiani, O., Caciagli, F., & Ciccarelli, R. (1996) · Neuroreport · doi:10.1097/00001756-199611040-00026 · Cited by 149 · see citing works

Glutamate and ATP signalling in white matter pathology

Matute, C. (2011) · Journal of Anatomy · doi:10.1111/j.1469-7580.2010.01339.x · Cited by 149 · see citing works

Activation of adenosine A3 receptor suppresses lipopolysaccharide-induced TNF-α production through inhibition of PI 3-kinase/Akt and NF-κB activation in murine BV2 microglial cells

Lee, J. Y., Jhun, B. S., Oh, Y. T., Lee, J. H., Choe, W., Baik, H. H., Ha, J., Yoon, K., Kim, S. S., & Kang, I. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.11.004 · Cited by 148 · see citing works

Dopamine D1 Receptor‐mediated Facilitation of GABAergic Neurotransmission in the Rat Strioentopeduncular Pathway and its Modulation by Adenosine A1 Receptor‐mediated Mechanisms

Ferré, S., O'Connor, W. T., Svenningsson, P., Björklund, L., Lindberg, J., Tinner, B., Strömberg, I., Goldstein, M., Ögren, S. O., Ungerstedt, U., et al. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01617.x · Cited by 147 · see citing works

Nitration of Hsp90 induces cell death

Franco, M. C., Ye, Y., Refakis, C. A., Feldman, J. L., Stokes, A. L., Basso, M., de Mera, R. M. M.-F., Sparrow, N. A., Calingasan, N. Y., Kiaei, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215177110 · Cited by 146 · see citing works

Protecting Motor Neurons from Toxic Insult by Antagonism of Adenosine A2a and Trk Receptors

Mojsilovic‐Petrovic, J., Jeong, G., Crocker, A. J., Arneja, A., David, S., Russell, D., & Kalb, R. G. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1856-06.2006 · Cited by 145 · see citing works

Synapse–Glia Interactions at the Mammalian Neuromuscular Junction

Rochon, D., Rousse, I., & Robitaille, R. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-11-03819.2001 · Cited by 145 · see citing works

Familial aggregation of Parkinson’s disease

Elbaz, A., Grigoletto, F., Baldereschi, M., Breteler, M. M. B., Manubens-Bertran, J. M., Pousa, S. L., Dartigues, J.-F., Alpérovitch, A., Tzourio, C., & Rocca, W. A. (1999) · Neurology · doi:10.1212/wnl.52.9.1876 · Cited by 145 · see citing works

Untitled work

Ullrich (2018) · doi:10.1038/mp.2017.188 · Cited by 145 · see citing works

Increased 5-Methylcytosine and Decreased 5-Hydroxymethylcytosine Levels are Associated with Reduced Striatal A2AR Levels in Huntington’s Disease

Villar-Menéndez, I., Blanch, M., Tyebji, S., Pereira‐Veiga, T., Albasanz, J. L., Martı́n, M., Ferrer, I., Pérez‐Navarro, E., & Barrachina, M. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8219-0 · Cited by 144 · see citing works

Inhibitory and excitatory effects of adenosine receptor agonists on evoked transmitter release from phrenic nerve endings of the rat

Correia‐de‐Sá, P., Sebastião, A. M., & Ribeiro, J. A. (1991) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1991.tb09836.x · Cited by 144 · see citing works

Inhibition of UDP/P2Y6 purinergic signaling prevents phagocytosis of viable neurons by activated microglia in vitro and in vivo

Neher, J. J., Neniškytė, U., Hornik, T. C., & Brown, G. C. (2014) · Glia · doi:10.1002/glia.22693 · Cited by 143 · see citing works

Immunometabolism: Molecular Mechanisms, Diseases, and Therapies 2018

Neto, J. C. R., Lira, F. S., Festuccia, W. T., Wessner, B., & BISHOP, N. C. (2019) · Mediators of Inflammation · doi:10.1155/2019/2340914 · Cited by 140 · see citing works

Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer

Kazemi, M., Mohseni, S. R., Hojjat-Farsangi, M., Anvari, E., Ghalamfarsa, G., Mohammadi, H., & Jadidi-Niaragh, F. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.25873 · Cited by 139 · see citing works

Purinergic receptors and their activation by endogenous purines at perisynaptic glial cells of the frog neuromuscular junction

Robitaille, R. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07121.1995 · Cited by 138 · see citing works

The Influence of Caffeine on Voluntary Muscle Activation

Kalmar, J. M. (2005) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000178219.18086.9e · Cited by 134 · see citing works

Role of the Central Ascending Neurotransmitter Systems in the Psychostimulant Effects of Caffeine

Ferré, S. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1400 · Cited by 133 · see citing works

The Proinflammatory Action of Microglial P2 Receptors Is Enhanced in SOD1 Models for Amyotrophic Lateral Sclerosis

D'Ambrosi, N., Finocchi, P., Apolloni, S., Cozzolino, M., Ferri, A., Padovano, V., Pietrini, G., Carrì, M. T., & Volonté, C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901212 · Cited by 131 · see citing works

Exacerbation of Experimental Autoimmune Encephalomyelitis in P2X7R−/− Mice: Evidence for Loss of Apoptotic Activity in Lymphocytes

Chen, L., & Brosnan, C. F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.5.3115 · Cited by 130 · see citing works

The P2X7 receptor antagonist Brilliant Blue G attenuates contralateral rotations in a rat model of Parkinsonism through a combined control of synaptotoxicity, neurotoxicity and gliosis

do Carmo, M. R. S., Menezes, A. P. F., Nunes, A. C. L., Pliássova, A., Rolo, A. P., Palmeira, C. M., Cunha, R. A., Canas, P. M., & de Andrade, G. M. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.01.045 · Cited by 129 · see citing works

Neurotransmitter‐mediated calcium signalling in oligodendrocyte physiology and pathology

Butt, A. M. (2006) · Glia · doi:10.1002/glia.20424 · Cited by 128 · see citing works

The NADPH Oxidase Pathway Is Dysregulated by the P2X7 Receptor in the SOD1-G93A Microglia Model of Amyotrophic Lateral Sclerosis

Apolloni, S., Parisi, C., Pesaresi, M. G., Rossi, S., Carrı̀, M. T., Cozzolino, M., Volonté, C., & D’Ambrosi, N. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203262 · Cited by 128 · see citing works

Purinergic cotransmission

Burnstock, G. (2008) · Experimental Physiology · doi:10.1113/expphysiol.2008.043620 · Cited by 128 · see citing works

The therapeutic potential of purinergic signalling

Burnstock, G. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.07.016 · Cited by 127 · see citing works

MicroRNA-125b regulates microglia activation and motor neuron death in ALS

Parisi, C., Napoli, G., Amadio, S., Spalloni, A., Apolloni, S., Longone, P., & Volonté, C. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.153 · Cited by 127 · see citing works

Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics

Ortiz, R., Ulrich, H., Zarate, C. A., & Machado‐Vieira, R. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.10.016 · Cited by 126 · see citing works

Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection

Witting, A., Chen, L., Cudaback, E., Straiker, A. J., Walter, L. M., Rickman, B. H., Möller, T., Brosnan, C. F., & Stella, N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510418103 · Cited by 125 · see citing works

P2X7 receptor is critical in α-synuclein–mediated microglial NADPH oxidase activation

Jiang, T., Hoekstra, J., Heng, X., Kang, W., Ding, J., Liu, J., Chen, S., & Zhang, J. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.03.015 · Cited by 123 · see citing works

Purinergic signalling in the musculoskeletal system

Burnstock, G., Arnett, T. R., & Orriss, I. R. (2013) · Purinergic Signalling · doi:10.1007/s11302-013-9381-4 · Cited by 121 · see citing works

Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson’s disease

Popat, R. A., Eeden, S. K. V. D., Tanner, C. M., Kamel, F., Umbach, D. M., Marder, K. S., Mayeux, R. P., Ritz, B. R., Ross, G. W., Petrovitch, H., et al. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03353.x · Cited by 119 · see citing works

Inflammation in EAE: Role of chemokine/cytokine expression by resident and infiltrating cells

Eng, L. F., Ghirnikar, R. S., & Lee, Y. L. (1996) · Neurochemical Research · doi:10.1007/bf02527717 · Cited by 117 · see citing works

Pathological overproduction: the bad side of adenosine

Borea, P. A., Gessi, S., Merighi, S., Vincenzi, F., & Varani, K. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13763 · Cited by 117 · see citing works

P2X7 Receptor Signaling Pathway as a Therapeutic Target for Neurodegenerative Diseases

Takenouchi, T., Sekiyama, K., Sekigawa, A., Fujita, M., Waragai, M., Sugama, S., Iwamaru, Y., Kitani, H., & Hashimoto, M. (2010) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-010-0069-y · Cited by 116 · see citing works

Uridine 5′-Diphosphate Induces Chemokine Expression in Microglia and Astrocytes through Activation of the P2Y6 Receptor

Kim, B., Jeong, H., Kim, J.-H., Lee, S. Y., Jou, I., & Joe, E. (2011) · Journal of Immunology · doi:10.4049/jimmunol.1000212 · Cited by 115 · see citing works

Neurotransmitter receptor heteromers and their integrative role in ‘local modules’: The striatal spine module

Ferré, S., Agnati, L. F., Ciruela, F., Lluı́s, C., Woods, A. S., Fuxé, K., & Franco, R. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.01.007 · Cited by 113 · see citing works

Functions, dysfunctions and possible therapeutic relevance of adenosine A2A receptors in Huntington's disease

Popoli, P., Blum, D. L., Martire, A., Ledent, C. A., Ceruti, S., & Abbracchio, M. P. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.12.005 · Cited by 110 · see citing works

Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis

Apolloni, S., Amadio, S., Montilli, C., Volonte, C., & D'Ambrosi, N. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt259 · Cited by 109 · see citing works

Blocking A2B Adenosine Receptor Alleviates Pathogenesis of Experimental Autoimmune Encephalomyelitis via Inhibition of IL-6 Production and Th17 Differentiation

Wei, W., Du, C., Lv, J., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103721 · Cited by 109 · see citing works

Diminished adenosine A1 receptor expression on macrophages in brain and blood of patients with multiple sclerosis

Johnston, J. B., Silva, C. G., Gonzalez, G. C., Holden, J. K., Warren, K. G., Metz, L. M., & Power, C. (2001) · Annals of Neurology · doi:10.1002/ana.1007 · Cited by 105 · see citing works

A2A Adenosine Receptor Signaling in Lymphocytes and the Central Nervous System Regulates Inflammation during Experimental Autoimmune Encephalomyelitis

Mills, J. H., Kim, D.-G., Krenz, A., Chen, J., & Bynoe, M. S. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200545 · Cited by 104 · see citing works

Purinergic mechanisms in neuroinflammation: An update from molecules to behavior

Beamer, E. H., Gölöncsér, F., Horváth, G., Bekő, K., Otrokocsi, L., Koványi, B., & Sperlágh, B. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.09.019 · Cited by 103 · see citing works

The ectonucleotidase cd39/ENTPDase1 modulates purinergic‐mediated microglial migration

Färber, K., Markworth, S., Pannasch, U., Nolte, C., Prinz, V., Kronenberg, G., Gertz, K. R., Endres, M., Bechmann, I., Enjyoji, K., et al. (2007) · Glia · doi:10.1002/glia.20606 · Cited by 102 · see citing works

Pivotal Role of Adenosine Neurotransmission in Restless Legs Syndrome

Ferré, S., Quiroz, C., Guitart, X., Rea, W. P., Seyedian, A., Moreno, E., Casadó-Anguera, V., Díaz‐Ríos, M., Casadó, V., Clemens, S., et al. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00722 · Cited by 102 · see citing works

Adenosine A2A Receptors in Secondary Progressive Multiple Sclerosis: A [11C]TMSX Brain PET Study

Rissanen, E., Virta, J. R., Paavilainen, T., Tuisku, J., Helin, S., Luoto, P., Parkkola, R. K., Rinne, J. O., & Airas, L. M. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.85 · Cited by 100 · see citing works

Foxo3a induces motoneuron death through the Fas pathway in cooperation with JNK

Barthélémy, C., Henderson, C. E., & Pettmann, B. (2004) · BMC Neuroscience · doi:10.1186/1471-2202-5-48 · Cited by 100 · see citing works

Adenosine A2A receptor antagonism reverses inflammation-induced impairment of microglial process extension in a model of Parkinson's disease

Gyoneva, S., Shapiro, L. P., Lazo, C. R., Garnier‐Amblard, E. C., Smith, Y., Miller, G. W., & Traynelis, S. F. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.03.004 · Cited by 97 · see citing works

On the role of P2X7 receptors in dopamine nerve cell degeneration in a rat model of Parkinson’s disease: studies with the P2X7 receptor antagonist A-438079

Marcellino, D., Suárez-Boomgaard, D., Sánchez-Reina, M. D., Aguirre, J. A., Yoshitake, T., Yoshitake, S., Hagman, B., Kehr, J., Agnati, L. F., Fuxe, K., et al. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0400-0 · Cited by 97 · see citing works

Purinergic receptors in psychiatric disorders

Krügel, U. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.032 · Cited by 95 · see citing works

P2X7 receptors on microglial cells mediate injury to cortical neurons in vitro

Skaper, S. D., Facci, L., Culbert, A. A., Evans, N. A., Chessell, I. P., Davis, J. B., & Richardson, J. C. (2006) · Glia · doi:10.1002/glia.20379 · Cited by 94 · see citing works

Adenosine A2A receptor gene disruption protects in an α‐synuclein model of Parkinson's disease

Kachroo, A., & Schwarzschild, M. A. (2011) · Annals of Neurology · doi:10.1002/ana.22630 · Cited by 94 · see citing works

Adenosine A2AReceptors Modulate α-Synuclein Aggregation and Toxicity

Ferreira, D. G., Batalha, V. L., Miranda, H. V., Coelho, J. E., Gomes, R., Gonçalves, F. Q., Real, J. I., Rino, J., Albino‐Teixeira, A., Cunha, R. A., et al. (2015) · Cerebral Cortex · doi:10.1093/cercor/bhv268 · Cited by 93 · see citing works

Chapter 19 Role of endogenous nitric oxide and peroxynitrite formation in the survival and death of motor neurons in culture

Estévez, Á. G., Spear, N., Manuel, S. M., Barbeito, L., Radí, R., & Beckman, J. S. (1998) · Progress in brain research · doi:10.1016/s0079-6123(08)63214-8 · Cited by 91 · see citing works

Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington's disease models

Li, W., Silva, H. B. L., Real, J. I., Wang, Y., Rial, D., Li, P., Payen, M.-P., Zhou, Y., Müller, C. E., Tomé, Â. R., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.03.030 · Cited by 91 · see citing works

Aberrant amplification of A 2A receptor signaling in striatal cells expressing mutant huntingtin

Varani, K., Rigamonti, D., Sipione, S., Camurri, A., Borea, P. A., Cattabeni, F., Abbracchio, M. P., & Cattaneo, E. F. (2001) · The FASEB Journal · doi:10.1096/fj.00-0730fje · Cited by 91 · see citing works

Deletion of the BDNF Truncated Receptor TrkB.T1 Delays Disease Onset in a Mouse Model of Amyotrophic Lateral Sclerosis

Yanpallewar, S. U., Barrick, C. A., Buckley, H., Becker, J., & Tessarollo, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039946 · Cited by 90 · see citing works

Caffeine and adenosine A2A receptor inactivation decrease striatal neuropathology in a lentiviral‐based model of Machado–Joseph disease

Gonçalves, N., Simões, A., Cunha, R. A., & de Almeida, L. P. (2013) · Annals of Neurology · doi:10.1002/ana.23866 · Cited by 90 · see citing works

cAMP-response Element-binding Protein Contributes to Suppression of the A2A Adenosine Receptor Promoter by Mutant Huntingtin with Expanded Polyglutamine Residues

Chiang, M., Lee, Y., Huang, C., & Chern, Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413279200 · Cited by 89 · see citing works

Purinergic receptors in embryonic and adult neurogenesis

Oliveira‐Giacomelli, Á., Illés, P., & Ulrich, H. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.008 · Cited by 88 · see citing works

Targeting adenosine in cancer immunotherapy: a review of recent progress

Whiteside, T. L. (2017) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2017.1316197 · Cited by 87 · see citing works

Purinergic Receptors in Adipose Tissue As Potential Targets in Metabolic Disorders

Tozzi, M., & Novak, I. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00878 · Cited by 87 · see citing works

Neuron–microglia interaction by purinergic signaling in neuropathic pain following neurodegeneration

Tsuda, M., & Inoue, K. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.08.042 · Cited by 86 · see citing works

GDNF but not BDNF is increased in cerebrospinal fluid in amyotrophic lateral sclerosis

Grundström, E., Lindholm, D., Johansson, A., Blennow, K., & Askmark, H. (2000) · Neuroreport · doi:10.1097/00001756-200006050-00037 · Cited by 86 · see citing works

Connexins and pannexins: At the junction of neuro‐glial homeostasis & disease

Lapato, A. S., & Tiwari-Woodruff, S. K. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24088 · Cited by 85 · see citing works

Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases

Madeira, M. H., Boia, R., Ambrósio, A. F., & Santiago, A. R. (2017) · Mediators of Inflammation · doi:10.1155/2017/4761081 · Cited by 84 · see citing works

Aberrant A 2A receptor function in peripheral blood cells in Huntington's disease

Varani, K., Abbracchio, M. P., Cannella, M., Cislaghi, G., Giallonardo, P., Mariotti, C., Cattabriga, E., Cattabeni, F., Borea, P. A., Squitieri, F., et al. (2003) · The FASEB Journal · doi:10.1096/fj.03-0079fje · Cited by 82 · see citing works

A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease

Dhaenens, C., Burnouf, S., Simonin, C., Brussel, E. V., Duhamel, A., Defebvre, L., Duru, C., Vuillaume, I., Cazeneuve, C., Charles, P., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.06.009 · Cited by 80 · see citing works

Strong P2X4 purinergic receptor‐like immunoreactivity is selectively associated with degenerating neurons in transgenic rodent models of amyotrophic lateral sclerosis

Casanovas, A., Hernández, S., Tarabal, O., Rosselló, J., & Esquerda, J. E. (2007) · The Journal of Comparative Neurology · doi:10.1002/cne.21527 · Cited by 78 · see citing works

Early and transient alteration of adenosine A2A receptor signaling in a mouse model of Huntington disease

Tarditi, A., Camurri, A., Varani, K., Borea, P. A., Woodman, B., Bates, G. P., Cattaneo, E. F., & Abbracchio, M. P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.01.014 · Cited by 77 · see citing works

High consumption of coffee is associated with decreased multiple sclerosis risk; results from two independent studies

Hedström, A. K., Mowry, E. M., Gianfrancesco, M. A., Shao, X., Schaefer, C. A., Shen, L., Olsson, T., Barcellos, L. F., & Alfredsson, L. (2016) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-312176 · Cited by 77 · see citing works

New concepts in the management of restless legs syndrome

Garcı́a-Borreguero, D., & Pumarega, I. C. (2017) · BMJ · doi:10.1136/bmj.j104 · Cited by 77 · see citing works

An overview of the patient with ataxia

Mariotti, C., Fancellu, R., & Donato, S. D. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0814-z · Cited by 76 · see citing works

Genetic inactivation of the adenosine A2A receptor exacerbates brain damage in mice with experimental autoimmune encephalomyelitis

Yao, S., Li, Z.-Z., Huang, Q., Li, F., Wang, Z., Augusto, E., He, J., Wang, X., Chen, J., & Zheng, R. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07807.x · Cited by 75 · see citing works

Gain-of-function of P2X7 receptor gene variants in multiple sclerosis

Oyanguren-Desez, O., Antigüedad, A. R., Villoslada, P., Domercq, M., Alberdi, E. M., & Matute, C. (2011) · Cell Calcium · doi:10.1016/j.ceca.2011.08.002 · Cited by 75 · see citing works

Purine nucleosides in neuroregeneration and neuroprotection

Ribeiro, F. F., Xapelli, S., Miranda‐Lourenço, C., Tanqueiro, S. R., Fonseca‐Gomes, J., Diógenes, M. J., Ribeiro, J. A., & Sebastião, A. M. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.11.006 · Cited by 74 · see citing works

The Adenosine A1Receptor Agonist Adenosine Amine Congener Exerts a Neuroprotective Effect against the Development of Striatal Lesions and Motor Impairments in the 3-Nitropropionic Acid Model of Neurotoxicity

Blum, D. L., Gall, D., Galas, M., d’Alcantara, P., Bantubungi, K., & Schiffmann, S. N. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-20-09122.2002 · Cited by 73 · see citing works

Nerve injury induces glial cell line‐derived neurotrophic factor (gdnf) expression in schwann cells through purinergic signaling and the pkc‐pkd pathway

Xu, P., Rosen, K. M., Hedstrom, K. L., Rey, O., Guha, S., Hart, C., & Corfas, G. (2013) · Glia · doi:10.1002/glia.22491 · Cited by 73 · see citing works

Developmental expression of metabotropic P2Y1 and P2Y2 receptors in freshly isolated astrocytes from rat hippocampus

Zhu, Y., & Kimelberg, H. K. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00241.x · Cited by 73 · see citing works

Association between caffeine intake and age at onset in Huntington's disease

Simonin, C., Duru, C., Salleron, J., Hincker, P., Charles, P., Delval, A., Youssov, K., Burnouf, S., Azulay, J., Verny, C., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.05.013 · Cited by 73 · see citing works

A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis

Gu, B. J., Field, J., Dutertre, S., Ou, A., Kilpatrick, T. J., Lechner‐Scott, J., Scott, R. J., Lea, R. A., Taylor, B. V., Stankovich, J. M., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv278 · Cited by 73 · see citing works

P2Y12 receptor protein in cortical gray matter lesions in multiple sclerosis.

Amadio, S., Montilli, C., Magliozzi, R., Bernardi, G., Reynolds, R., & Volonte, C. (2010) · Cerebral Cortex · doi:10.1093/cercor/bhp193 · Cited by 73 · see citing works

Adenosinergic Protection of Dopaminergic and GABAergic Neurons against Mitochondrial Inhibition through Receptors Located in the Substantia Nigra and Striatum, Respectively

Alfinito, P. D., Wang, S.-P., Manzino, L., Rijhsinghani, S., Zeevalk, G. D., & Sonsalla, P. K. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-34-10982.2003 · Cited by 72 · see citing works

The P2X7 Receptor: Central Hub of Brain Diseases

Andrejew, R., Oliveira-Giacomelli, Á., Ribeiro, D. E., Glaser, T., Arnaud-Sampaio, V. F., Lameu, C., & Ulrich, H. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00124 · Cited by 162 · see citing works

Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology

Ribeiro, D. E., Oliveira-Giacomelli, Á., Glaser, T., Arnaud-Sampaio, V. F., Andrejew, R., Dieckmann, L., Baranova, J., Lameu, C., Ratajczak, M. Z., & Ulrich, H. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00965-3 · Cited by 145 · see citing works

P2Y6 and P2X7 Receptor Antagonism Exerts Neuroprotective/ Neuroregenerative Effects in an Animal Model of Parkinson’s Disease

Oliveira-Giacomelli, Á., M. Albino, C., de Souza, H. D. N., Corrêa-Velloso, J., de Jesus Santos, A. P., Baranova, J., & Ulrich, H. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00476 · Cited by 60 · see citing works

Phosphoinositides: Roles in the Development of Microglial-Mediated Neuroinflammation and Neurodegeneration

Ernest James Phillips, T., & Maguire, E. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.652593 · Cited by 33 · see citing works

The impact of commercially available purinergic ligands on purinergic signalling research

Flanaghan, J. R., & Roome, S. J. (2011) · Purinergic Signalling · doi:10.1007/s11302-011-9269-0

Purinergic signaling in schistosomal infection

Silva, C. L. M. (2016) · Biomedical Journal · doi:10.1016/j.bj.2016.06.006 · Cited by 16 · see citing works

Extracellular nucleotides and nucleosides : release, receptors, and physiological and pathophysiological effects

Schwiebert, E. M. (2003) · Cited by 17 · see citing works

Purinergic signalling: Its unpopular beginning, its acceptance and its exciting future

Burnstock, G. (2012) · BioEssays · doi:10.1002/bies.201100130 · Cited by 209 · see citing works

The participation of plasma membrane hemichannels to purinergic signaling

Baroja‐Mazo, A., Barberà-Cremades, M., & Pelegrı́n, P. (2012) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2012.01.002 · Cited by 173 · see citing works